This recommendation is an update of one of the 49 recommendations that were published in the WHO recommendations on antenatal care for a positive pregnancy experience. The recommendation was developed initially using the standardized operating procedures described in the WHO handbook for guideline develo...
The objective of this guideline is to present the complete set of all WHO recommendations and best practice statements relating to abortion. While legal, regulatory, policy and service-delivery contexts may vary from country to country, the recommendations and best practices described in this document ai...
The objective of this guideline is to present the complete set of all WHO recommendations and best practice statements relating to abortion. While legal, regulatory, policy and service-delivery contexts may vary from country to country, the recommendations and best practices described in this document ai...
In 2019, the Executive Guideline Steering Group (GSG) for the World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating the then current WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia. This decision was based on new evidence on the ...
Evidence from a systematic review on antenatal zinc supplementation was evaluated as part of the World
Health Organization (WHO) antenatal care (ANC) guideline development process in 2016, and the following
recommendation on zinc supplementation was made: “Zinc supplementation for pregnant women is onl...
The postnatal period, defined here as the period beginning immediately after the birth of the baby and extending
up to six weeks (42 days), is a critical time for women, newborns, partners, parents, caregivers and families. Yet,
during this period, the burden of maternal and neonatal mortality and morbid...
Hypertensive disorders of pregnancy are an
important cause of severe morbidity, long-term
disability and death among both pregnant women
and their babies, and account for approximately
14% of all maternal deaths worldwide. Improving
care for women around the time of childbirth is
a necessary step towards...
The Department of Reproductive Health and Research of the World Health Organization
gratefully acknowledges the contributions of many individuals and organizations to
the updating of these recommendations. Work on this update was coordinated by
Olufemi Oladapo, Joshua Vogel and A. Metin Gülmezoglu of th...
This document is part of the process for improving the quality of care in family planning. Medical eligibility criteria for contraceptive use (MEC), the first edition of which was published in 1996, presents current WHO guidance on the safety of various contraceptive methods for use in the context of spe...
These guidelines were produced by the Department of Reproductive Health and Research (RHR), World Health Organization (WHO), under the leadership of Dr Claudia García-Moreno. The expertise and support of many people have made the development of these guidelines possible. The guideline development proces...
